The biotech industry in Alberta is growing, with approximately 75% of the sector focused on innovative health treatments and products. This includes 38% of companies in the business of creating medical devices and 23% in the business of biotechnology and pharmaceuticals.

Just over 60% of firms in the biotech business call Edmonton home, making the city the biotech hub for the province. The pharmaceutical industry is specifically noteworthy as an emerging industry in the city with the entry of large pharmaceutical players such as Gilead, Naeja, McKesson Pharmaceutical and Aurinia Pharmaceuticals Inc. 

Overall, the province of Alberta is recognized nationally and internationally for expertise in neurology, diabetes and islet transplantation research, cardiology, cancer research and treatment, bone and joint research and vaccines for infection diseases.